candesartan cilexetil and D-fructopyranose

candesartan cilexetil has been researched along with D-fructopyranose in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higashiura, K; Hirata, A; Iimura, O; Masuda, A; Matsuda, K; Miyazaki, Y; Nakagawa, M; Shimamoto, K; Takizawa, H; Ura, N1
Higashiura, K; Iimura, O; Matsuda, K; Shimamoto, K; Takizawa, H; Ura, N1
Fujioka, Y; Higaki, J; Ikegami, H; Kawaguchi, N; Kobayashi, R; Mikami, H; Nagano, M; Nakamura, F; Ogihara, T; Onishi, S1
Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I1
Chen, S; Izumida, T; Katayama, S; Noguchi, Y; Tatebe, J1
Jiang, HY; Kawata, Y; Koike, T; Li, P; Oshida, Y; Wang, ZH1
Hashikawa, N; Hashikawa-Hobara, N; Inoue, Y; Kawasaki, H; Sanda, H; Takatori, S; Zamami, Y1
Dudhipala, N; Veerabrahma, K1

Trials

1 trial(s) available for candesartan cilexetil and D-fructopyranose

ArticleYear
Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.
    American journal of hypertension, 1995, Volume: 8, Issue:4 Pt 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diet; Fructose; Glucose Clamp Technique; Humans; Hypertension; Indans; Insulin Resistance; Male; Middle Aged; Rats; Rats, Sprague-Dawley; Tetrazoles

1995

Other Studies

7 other study(ies) available for candesartan cilexetil and D-fructopyranose

ArticleYear
Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
    Blood pressure. Supplement, 1994, Volume: 5

    Topics: Angiotensin Receptor Antagonists; Animal Feed; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Fructose; Insulin Resistance; Male; Prodrugs; Rats; Rats, Sprague-Dawley; Tetrazoles

1994
Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:6 Pt 2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Fructose; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley; Tetrazoles

1993
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1996, Volume: 18, Issue:5

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Child; Diet; Fructose; Glucose; Glucose Intolerance; Humans; Hyperinsulinism; Hypertension; Insulin Resistance; Male; Rats; Rats, Wistar; Tetrazoles

1996
A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
    Journal of hypertension, 1996, Volume: 14, Issue:11

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Captopril; Chromans; Diet; Fructose; Hypoglycemic Agents; Insulin Resistance; Male; Monosaccharide Transport Proteins; Rats; Rats, Wistar; Tetrazoles; Thiazoles; Thiazolidinediones; Troglitazone

1996
Acute treatment with candesartan cilexetil, an angiotensin II type 1 receptor blocker, improves insulin sensitivity in high-fructose-diet-fed rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2012, Volume: 44, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Humans; Insulin Resistance; Male; Muscle, Skeletal; Rats; Rats, Wistar; Tetrazoles

2012
Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats.
    Diabetes, 2012, Volume: 61, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Fructose; Gene Expression Regulation; Insulin; Insulin Resistance; Neurites; Nociception; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptor, Angiotensin, Type 2; Signal Transduction; Tetrazoles

2012
Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Drug delivery, 2016, Volume: 23, Issue:2

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biological Availability; Biphenyl Compounds; Blood Pressure; Calorimetry, Differential Scanning; Crystallography, X-Ray; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Stability; Fructose; Hypertension; Lipids; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Particle Size; Powder Diffraction; Rats, Wistar; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical; Tetrazoles; Ultrasonics

2016